Câncer esofágico

Associate Professor

Thoracic and Cardiovascular Surgery

University of Texas MD Anderson Cancer Center

Houston

TX

Declarações

RR is a research consultant for Johnson & Johnson and an educational proctor for Intuitive Surgical.

​Assistant Professor

Gastrointestinal Medical Oncology

University of Texas MD Anderson Cancer Center

Houston

TX

Declarações

JJL has participated in advisory boards for BeOne Medicines and Gilead Sciences and conducted an educational workshop for AstraZeneca.

Dr Ravi Rajaram and Dr Jenny Jing Li would like to gratefully acknowledge Dr Naureen Starling, Dr Caroline Fong, Dr Mark J. Krasna, and Dr Ghulam Abbas, the previous contributors to this topic.

Declarações

MJK is an author of several references cited in this topic. GA declares that he has no competing interests. NS has received research funding from AstraZeneca, BMS, and Pfizer; travel and accommodation funding from AstraZeneca, BMS, Eli Lilly, Merck, Roche, and MSD Oncology; honoraria from Eli Lilly, Merck Serono, MSD Oncology, Pierre Fabre, Servier, GSK, and Amgen. She has been on the advisory board for Pfizer, AstraZeneca, Servier, and MSD (Merck). NS is an Honorary Clinical Senior Lecturer within the Division of Clinical Studies at the Institute of Cancer Research and serves on the UK National Cancer Research Institute (NCRI) oesophagogastric sub-group. NS has acted as a clinical expert in oesophagogastric cancer for NICE (guideline committee and technology appraisal) and is an upper GI expert for International Cancer Benchmarking Partnership. She is a Trustee for Pancreatic Cancer UK and a member of the EORTC General Assembly representing The Royal Marsden, as well as a member of the European Society for Medical Oncology (ESMO) Gastrointestinal Faculty. Educational roles include the NIHR Training Lead for NIHR Biomedical Research Centre, member of the Cancer Research Centre of Excellence training committee, Deputy Training Program Director (one of three) for South London Medical Oncology Training, member of the pan-London specialist Medical oncology training committee, and member of the Medical Oncology National Recruitment steering committee. CF declares that she has received honoraria from Bristol Myers Squibb.

Assistant Professor

Moffitt Cancer Center

University of South Florida

Tampa

FL

Declarações

SM declares that he has no competing interests.

Clinical Reader in Surgery

Nuffield Department of Surgery

University of Oxford

Oxford

UK

Declarações

PM declares that he has no competing interests.

Assistant Professor of Oncology

Roswell Park Cancer Institute

Buffalo

NY

Declarações

NIK has received funding for the conduction of clinical trials and associated translational studies from Merck, Pfizer, and Astra-Zeneca. NIK has a grant from the National Comprehensive Cancer Network (from research support by Roche).